Interim Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| EXPENSES | ||||
| Officers and directors fees (Note 7 &10) | $ 86,351 | $ 33,799 | $ 237,777 | $ 100,247 |
| Legal fees | 123,867 | 162,365 | 470,145 | 624,865 |
| Office & general | 69,952 | 49,611 | 234,406 | 168,062 |
| Patent consulting fees | 6,348 | 4,749 | 14,345 | 13,274 |
| Professional fees & services (recovery) (Note 10) | 929,671 | (438,711) | 3,103,494 | 781,668 |
| Total expenses (recovery) | 1,216,189 | (188,187) | 4,060,167 | 1,688,116 |
| INCOME (LOSS) BEFORE OTHER EXPENSE | (1,216,189) | 188,187 | (4,060,167) | (1,688,116) |
| OTHER EXPENSE | ||||
| Loss on settlement of accounts payable | 104,500 | 34,763 | ||
| INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) FOR THE PERIOD | $ (1,216,189) | $ 188,187 | $ (4,164,667) | $ (1,722,879) |
| Basic income (loss) per common share | $ (0.00) | $ 0.00 | $ (0.00) | $ (0.00) |
| Diluted income (loss) per common share | $ (0.00) | $ 0.00 | $ (0.00) | $ (0.00) |
| Weighted-average number of common shares outstanding, basic | 3,836,015,128 | 3,654,126,032 | 3,793,438,233 | 3,640,551,261 |
| Weighted-average number of common shares outstanding, diluted | 3,836,015,128 | 3,654,126,032 | 3,793,438,233 | 3,640,551,261 |
| X | ||||||||||
- Definition Expenses related to patent applications. No definition available.
|
| X | ||||||||||
- Definition Professional fees and services recovery. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for service provided by entity's director. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|